Issues about this dynamic have led some drug-plan scholars to search for substitute methods. Beau Kilmer, a co-director of RAND’S Drug Policy Investigate Center, has with his colleagues attempted to outline a spectrum of solutions concerning prohibition (punishing folks for selling or possessing a drug) and commercialization (permitting firms pro